Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results
March 03, 2020 06:00 ET
|
Neuronetics
MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call
February 18, 2020 08:00 ET
|
Neuronetics
MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
January 21, 2020 07:30 ET
|
Neuronetics
MALVERN, Pa., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Present at the 31st Annual Piper Jaffray Healthcare Conference
November 25, 2019 07:30 ET
|
Neuronetics
MALVERN, Pa., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Third Quarter 2019 Financial and Operating Results
November 05, 2019 07:30 ET
|
Neuronetics
MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics® Announces Appointment of Sheryl Conley to its Board of Directors
November 01, 2019 07:30 ET
|
Neuronetics
MALVERN, Pa., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call
October 22, 2019 07:30 ET
|
Neuronetics
MALVERN, Pa., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics Reports Second Quarter 2019 Financial and Operating Results
August 06, 2019 07:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference
July 25, 2019 16:30 ET
|
Neuronetics
MALVERN, Pa., July 25, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call
July 23, 2019 08:00 ET
|
Neuronetics
MALVERN, Pa., July 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...